U.S. Markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
85.92-1.49 (-1.70%)
At close: 1:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/21/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.34B1.53B1.80B1.17B1.75B1.75B
Enterprise Value 3
1.00B1.18B1.48B747.46M1.25B1.02B
Trailing P/E
4.16k250.84N/A2.283.523.06
Forward P/E 1
13.9117.6132.3621.1026.7424.88
PEG Ratio (5 yr expected) 1
0.931.172.161.411.341.24
Price/Sales (ttm)
9.6713.2018.8911.9414.3312.70
Price/Book (mrq)
1.922.212.721.522.061.68
Enterprise Value/Revenue 3
6.9928.3035.7622.5446.1941.06
Enterprise Value/EBITDA 6
22.31-1.49k38.41-48.2654.96-436.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.53
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3127.80
52 Week Low 357.24
50-Day Moving Average 387.87
200-Day Moving Average 3103.73

Share Statistics

Avg Vol (3 month) 3328.49k
Avg Vol (10 day) 3255.96k
Shares Outstanding 516.09M
Float 15.4M
% Held by Insiders 14.13%
% Held by Institutions 1146.08%
Shares Short (Nov 12, 2020) 410.63M
Short Ratio (Nov 12, 2020) 425.54
Short % of Float (Nov 12, 2020) 4114.23%
Short % of Shares Outstanding (Nov 12, 2020) 466.11%
Shares Short (prior month Oct 14, 2020) 410.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 01, 2010
Last Split Factor 21:6
Last Split Date 3Nov 18, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -11.23%
Operating Margin (ttm)4.99%

Management Effectiveness

Return on Assets (ttm)0.32%
Return on Equity (ttm)-2.08%

Income Statement

Revenue (ttm)143.43M
Revenue Per Share (ttm)8.71
Quarterly Revenue Growth (yoy)68.70%
Gross Profit (ttm)53.03M
EBITDA 41.64M
Net Income Avi to Common (ttm)-16.11M
Diluted EPS (ttm)-0.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)795.07M
Total Cash Per Share (mrq)49.41
Total Debt (mrq)459.92M
Total Debt/Equity (mrq)65.91
Current Ratio (mrq)20.28
Book Value Per Share (mrq)43.37

Cash Flow Statement

Operating Cash Flow (ttm)46.71M
Levered Free Cash Flow (ttm)47.35M